Hims & Hers Health (HIMS) Interest Coverage Ratio (2020 - 2026)
Hims & Hers Health (HIMS) reported Interest Coverage Ratio of 4.04 for Q1 2026, down 120.69% on a YoY basis from 19.54 in Q1 2025, and down 67.23% sequentially from 2.42 in Q4 2025.
Hims & Hers Health (HIMS) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Interest Coverage Ratio data on file, last reported at 4.04 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 120.69% year-over-year to 4.04; the trailing twelve-month figure through Mar 2026 stood at 1.58 (down 104.26% YoY), and the FY2025 full-year result was 0.62, up 85.5% from the prior year.
- Interest Coverage Ratio retreated to 4.04 in Q1 2026, from 2.42 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 19.54 in Q1 2025 to a low of 29.01 in Q4 2022.
- A 5-year average of 0.26 and a median of 0.14 in 2023 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio jumped 3018.9% in 2024 and tumbled 120.69% in 2026, its largest moves.
- Tracing HIMS's Interest Coverage Ratio over 5 years: stood at 29.01 in 2022, then surged by 97.7% to 0.67 in 2023, then soared by 2635.82% to 16.91 in 2024, then slumped by 114.3% to 2.42 in 2025, then sank by 67.23% to 4.04 in 2026.
- Business Quant data shows HIMS's Interest Coverage Ratio at 4.04 in Q1 2026, 2.42 in Q4 2025, and 0.03 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Hims & Hers Health | 7.48 Bn | 6.73 Bn | 396.79 Mn | -4.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.04 |
| Dec 31, 2025 | -2.42 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.08 |
| Mar 31, 2025 | 19.54 |
| Dec 31, 2024 | 16.91 |
| Sep 30, 2024 | 0.15 |
| Jun 30, 2024 | 0.06 |
| Mar 31, 2024 | 4.21 |
| Dec 31, 2023 | -0.67 |
| Sep 30, 2023 | -0.27 |
| Jun 30, 2023 | -0.13 |
| Mar 31, 2023 | -0.14 |
| Dec 31, 2022 | -29.01 |
| Sep 30, 2022 | -0.76 |
| Jun 30, 2022 | -1.10 |
| Mar 31, 2022 | -6.89 |
| Dec 31, 2021 | -53.91 |
| Sep 30, 2021 | -25.15 |
| Jun 30, 2021 | 46.42 |